Yahoo Web Search

Search results

    • Is CRISPR Therapeutics Stock a Buy?

      Is CRISPR Therapeutics Stock a Buy?

      Motley Fool via Yahoo Finance· 5 minutes ago

      Though that was an important milestone for the biotech, CRISPR Therapeutics remains unprofitable, and it is unlikely to launch another product in the...